Ecstasy induced acute hepatic failure. Case reports
Atayan, Y.; Çağın, Y.F.; Erdoğan, M.A.; Harputluoglu, M.M.M.; Bilgic, Y.
Acta Gastro-Enterologica Belgica 78(1): 53-55
2015
ISSN/ISBN: 1784-3227 PMID: 26118578 Document Number: 681247
3,4-methylenedioxymethamphetamine (MDMA), an amphetamine derivative known as ecstasy, has stimulating and hallucinogenic properties. It has become a substance that is widely used especially by young people. Hepatotoxicity is one of the rare side effects of this substance and can be fatal. Ecstasy-induced fulminant hepatitis has been reported in case reports. The clinical course and the prognosis of the cases may differ. In this article, two cases in whom ecstasy-induced fulminant hepatic failure had developed and who were treated with liver transplantation, and one case which recovered with treatment, have been presented.